• A study to evaluate the use of colchicine to reduce inflammation in patients with deep vein thrombosis.

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Italy
  • Effect of semaglutide, acetylsalicylic acid, and clopidogrel on blood clotting in patients with diabetes or overweight with cardiovascular disease

    Not yet recruiting

    3 1 1 1
    Italy
  • A study of RVU120 and everolimus for children with recurrent or progressive medulloblastoma

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Poland
  • A study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma

    Not yet recruiting

    1 1 1 1
    Greece
  • Study of ezabenlimab in patients with locally advanced head and neck cancer who have remaining signs of disease after chemoradiotherapy

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • A study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis

    Not yet recruiting

    2 1 1
    Germany Spain
  • A study to evaluate the safety and tolerability of azathioprine in patients with autosomal dominant polycystic kidney and liver disease

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • A study to evaluate the effect of survodutide on protein levels in the urine for patients with chronic kidney disease

    Not yet recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands Spain
  • A study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis

    Not yet recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Hungary Poland Spain
  • Study evaluating the omission of exemestane, letrozole, anastrozole, and tamoxifen in postmenopausal women with low-risk early breast cancer.

    Not yet recruiting

    2 1 1 1
    France

powered by